Speaker

Marcie McClintic Coates, JD, MBA
Senior Executive Advisor and Deputy Corporate Secretary to the Board of Directors
VIATRIS
Connect Online with this Speaker

Marcie McClintic Coates currently serves as Senior Executive Advisor and Counsel in the office of the Executive Chairman as well as Deputy Corporate Secretary to the Board of Directors of VIATRIS, a global healthcare company recently formed through the combination of Mylan and Pfizer’s Upjohn division, committed to empowering people worldwide to live healthier at every stage of life.  In her current role, McClintic Coates advises executive management and the Board on various strategic, business, legal, policy, operational and governance related matters.  She is a member of the Viatris leadership team and serves on the company’s corporate affairs council and corporate social responsibility advisory committee.      

In addition to her most recent work helping to ensure the successful launch of Viatris, McClintic Coates has held various global leadership roles throughout her nearly 15-year career at Mylan, including Head of Global Policy, Head of Global Regulatory Affairs, Vice President and Chief of Staff to the CEO and Global Regulatory Counsel. She is a proven leader of global teams, recognized for her consistent commitment to collaboration, inclusivity, and sustainability. 

With her unique background across many disciplines in healthcare, McClintic Coates has also become a recognized policy thought leader, representing the generic and biosimilar industries before Congress, the White House, HHS, FDA and in various international policy forums to increase patient access to more affordable medicine.   

McClintic Coates played a leading role in negotiating the $1.5 billion Generic Drug User Fee Act (GDUFA) of 2012 and 2017 with the FDA to improve access to safe and high-quality generic drugs. She also helped lead industry efforts for passage of the FDA Amendments Act of 2012, which updated antiquated U.S. law to ensure that all prescription drugs are held to the same high-quality standards regardless if made in the U.S. or abroad.  McClintic Coates has remained active in numerous advocacy efforts, including advancing solutions to help reduce out-of-pocket costs for Medicare patients, ensuring that trade and intellectual property laws balance both competition and innovation, and working with policymakers to harmonize regulatory requirements.  

In addition, McClintic Coates currently serves as vice chair of the Hugh O’Brian Youth Leadership organization, a nonprofit group devoted to developing high school student leaders to tackle the world’s biggest challenges beginning in their own communities. She also previously served on the Board of Directors of the Association for Accessible Medicines Board, the trade association representing the generic and biosimilar industry and served as chair of its membership committee.  

McClintic Coates holds a law degree and M.B.A. from West Virginia University where she served as Editor in Chief of the West Virginia Law Review and an undergraduate degree from Wittenberg University, where she graduated Summa Cum Laude. Prior to her time at Viatris and Mylan, she was an attorney in the Washington, D.C. office of the Baker & Daniels law firm, now known as Faegre Drinker.
 

SESSIONS: